IMPLANT SITE THROMBOSIS

IMPLANT SITE THROMBOSIS was reported 38 times

IMPLANT SITE THROMBOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human C1 Esterase Inhibitor [EPC] 1 0.0003
1 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 1 0.0001
2 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 1 0.0001
3 Progestin [EPC] 9 0.0000
4 HER2/neu Receptor Antagonist [EPC] 2 0.0000
5 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
6 Estrogen Receptor Antagonist [EPC] 1 0.0000
7 beta3-Adrenergic Agonist [EPC] 1 0.0000
8 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
9 Nitroimidazole Antimicrobial [EPC] 1 0.0000
10 Platinum-based Drug [EPC] 3 0.0000
11 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
12 Purine Antimetabolite [EPC] 1 0.0000
13 Parathyroid Hormone Analog [EPC] 1 0.0000
14 Aromatase Inhibitor [EPC] 1 0.0000
15 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
16 Factor Xa Inhibitor [EPC] 2 0.0000
17 Aldosterone Antagonist [EPC] 1 0.0000
18 Janus Kinase Inhibitor [EPC] 1 0.0000
19 Microtubule Inhibitor [EPC] 1 0.0000
20 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
21 Expectorant [EPC] 1 0.0000
22 Vitamin C [EPC] 2 0.0000
23 Loop Diuretic [EPC] 2 0.0000
24 Benzodiazepine [EPC] 3 0.0000
25 Alkylating Drug [EPC] 1 0.0000
26 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
27 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
28 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
29 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
30 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
31 Atypical Antipsychotic [EPC] 1 0.0000
32 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
33 Proton Pump Inhibitor [EPC] 1 0.0000
34 Corticosteroid [EPC] 1 0.0000